SCHEMBL23268985

SCHEMBL23268985

CS(=O)(=O)Nc1ccc(C2=NN(C(=O)C3CCCCC3)C(c3ccco3)C2)cc1

nearest known ligand 0.72

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PKM P14618 4/20 0.72
▸ ALDH1A1 P00352 6/20 0.70
▸ KDM4E B2RXH2 3/20 0.70
▸ LMNA P02545 2/20 0.70
▸ GLA P06280 1/20 0.70
▸ GAA P10253 1/20 0.70
▸ HPGD P15428 1/20 0.70
▸ HTT P42858 1/20 0.70
▸ BCL2 P10415 10/20 0.69
▸ BECN1 Q14457 10/20 0.69
▸ ITGB3 P05106 1/20 0.67
▸ ITGAV P06756 1/20 0.67
▸ NPC1 O15118 1/20 0.60
▸ POLB P06746 1/20 0.58
▸ MEN1 O00255 2/20 0.57
▸ MAPT P10636 2/20 0.57
▸ KMT2A Q03164 2/20 0.57
▸ SMN1; SMN2 Q16637 1/20 0.57
▸ L3MBTL1 Q9Y468 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23268960 0.86 PKM (0.80) PKMALDH1A1LMNABCL2BECN1
SCHEMBL23268986 0.84 PKM (1.00) PKMALDH1A1KDM4ELMNAGAA
SCHEMBL23268914 0.83 BCL2 (0.86) PKMALDH1A1KDM4EGAAHTT
SCHEMBL14133972 0.82 ALDH1A1 (0.71) PKMALDH1A1KDM4ELMNAGLA
SCHEMBL14133627 0.82 BCL2 (0.72) PKMALDH1A1KDM4ELMNAGLA
SCHEMBL14133808 0.81 ALDH1A1 (0.70) PKMALDH1A1KDM4ELMNAGLA
SCHEMBL23269372 0.81 BCL2 (1.00) PKMALDH1A1BCL2BECN1MEN1
SCHEMBL14133989 0.81 KDM4E (0.69) PKMALDH1A1KDM4ELMNAGLA
SCHEMBL23269265 0.81 BCL2 (1.00) PKMALDH1A1BCL2BECN1ITGB3
SCHEMBL23269361 0.81 BCL2 (1.00) PKMALDH1A1KDM4ELMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230203020-A1 Small molecule inducers of autophagy BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2023-06-29 — — US disclosed
US-20230203020-A1 Small molecule inducers of autophagy BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2023-06-29 — — US disclosed
US-11325898-B2 Small molecule inducers of autophagy BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2022-05-10 — — US disclosed
US-20210115024-A1 Small molecule inducers of autophagy BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2021-04-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11325898-B2 Small molecule inducers of autophagy BECN1, SQSTM1, MAP1LC3A PKM 4064/4885ALDH1A1 4649/4885KDM4E 2509/4885
US-20210115024-A1 Small molecule inducers of autophagy BECN1, SQSTM1, MAP1LC3A PKM 4064/4885ALDH1A1 4649/4885KDM4E 2509/4885
US-20230203020-A1 Small molecule inducers of autophagy BECN1, SQSTM1, MAP1LC3A PKM 4064/4885ALDH1A1 4649/4885KDM4E 2509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback